摘要
目的探讨内镜黏膜下挖除术（ESE）治疗胃固有肌层肿瘤的安全性及疗效。方法以2006年7月至2011年3月期间浙江省台州医院对起源于胃固有肌层的黏膜下肿瘤而行ESE治疗的116例患者为研究对象，分析术中、术后并发症及相应治疗情况，术后对上述病例进行胃镜随访。结果成功挖除肿瘤112例（96．6％），手术时间（51．9±16.3）min。术中出血9例（7．8％），术中穿孔20例（17．2％）。术后出血3例（2．6％），需外科干预5例（4．3％），其中术中4例，术后1例。术后未出现腹腔脓肿。腹膜炎等其他并发症；ESE术后平均住院6．1d；中位随访时间12个月，随访期内未发现肿瘤残留及复发。结论ESE治疗胃固有肌层肿瘤是安全可行的，近期疗效确切。
Objective To explore the efficacy and safety of endoscopic submucosal enucleation （ESE） for gastric submucosal tumors （SMTs） originated from muscularis propria. Methods A total of 116 patients with gastric SMT originated from muscularis propria underwent ESE in Department of Gastroenterology of the Taizhou Hospital between July 2006 and March 2011. The occurrence of intra- operative and post-operative complications and corresponding treatment were recorded. After the treatment of ESE, the patients were followed up endoscopically. Results The success rate of operation was 96.6%. The mean time of the procedure was （51.9±16.3） min. Complications included intra- operative bleeding （n=9, 7.8%）, perforation （n=20, 17.2%）, and post-operative bleeding （n=3, 2.6% ）. Among them, 5 cases （4.3%） required surgical intervention. None of patient had other complications such as peritoneal abscess or peritonitis. The mean hospitalization time after ESE was 6.1 days. The median follow-up period was 12 months （range, 3-48 months） and there was no residual tumor or recurrence. Conclusion ESE is a safe and feasible treatment for patients with gastric SMT originated from muscularis propria.
出处
《中华胃肠外科杂志》
CAS
2012年第11期1175-1177,共3页
Chinese Journal of Gastrointestinal Surgery
关键词
内镜黏膜下挖除术
胃黏膜下肿瘤
固有肌层
Endoscopic submucosal enucleation
Gastric submucosal tumors
Muscularispropria layer
